Latest News about TEVA
Recent news which mentions TEVA
Teva Suffers Loss In New York's Opioid Trial
January 03, 2022
From Benzinga
22 Stocks That Could Double Your Money in 2022
January 03, 2022
From Motley Fool
My Top 5 Portfolio Holdings for 2022
December 30, 2021
From Motley Fool
1 Healthcare Stock to Avoid in 2022
December 29, 2021
From Motley Fool
Teva Pharmaceuticals To Market Cannabis Oils From Cannabit-Tikun Olam In Israel, Palestine, Ukraine
December 27, 2021
Tickers
TEVA
From Benzinga
From Benzinga
7 of the Best Value Stocks for 2022 to Buy Now
December 15, 2021
From InvestorPlace
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
December 07, 2021
From InvestorPlace
2 Popular Healthcare Stocks I'd Avoid at All Costs
December 03, 2021
From Motley Fool
5 Warren Buffett Stocks Are Screaming Buys in December
December 03, 2021
From Motley Fool
3 Top Stocks That'll Make You Richer in December (and Beyond)
December 01, 2021
From Motley Fool
4 No-Brainer Buffett Stocks to Buy With $500 in November
November 08, 2021
From Motley Fool
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
From Benzinga
71 Biggest Movers From Yesterday
November 03, 2021
From Benzinga
Why Teva Pharmaceutical Stock Is Jumping Today
November 02, 2021
From Motley Fool
California Judge Rules For Drugmakers In Major Opioid Litigation
November 02, 2021
From Benzinga
24 Stocks Moving in Tuesday's Pre-Market Session
November 02, 2021
From Benzinga
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
November 01, 2021
Tickers
TEVA
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021
October 28, 2021
From Benzinga
Tickers
TEVA
From Motley Fool
Looking Into Teva Pharmaceutical Indus's Return On Capital Employed
October 27, 2021
Tickers
TEVA
From Benzinga
Teva Q3 Earnings Fall Short Of Expectations; Reaffirms FY21 Guidance
October 27, 2021
Tickers
TEVA
From Benzinga
Earnings Scheduled For October 27, 2021
October 27, 2021
From Benzinga
Xenon: Heading Toward Phase III With Strong Momentum
October 26, 2021
From InvestorPlace
Why Humana Is Suing Biogen
October 09, 2021
From Motley Fool
10 Health Care Stocks With Unusual Options Alerts In Today's Session
October 08, 2021
From Benzinga
5 Warren Buffett Stocks to Buy Hand Over Fist for the Fourth Quarter
October 08, 2021
From Motley Fool
From Benzinga
Teva Stops Production At U.S. Plant After FDA Concerns: Reports
October 04, 2021
Tickers
TEVA
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.